95 results
Page 3 of 5
8-K
EX-99.2
hrk7hzr39 8ur5oytotr
27 Jan 11
Receives U.S. Regulatory Approval for KOMBIGLYZE™ XR, and First-Line Indication for SPRYCEL® in Fourth Quarter
12:00am
8-K
5295n0iby9izg 15h2s
10 May 10
Amendments to Articles of Incorporation or Bylaws
12:00am
DEFA14A
dvhl9m2 vgoz
22 Mar 10
Additional proxy soliciting materials
12:00am
SC TO-I/A
ibdpbg42 tvhqzaorcho
7 Dec 09
Issuer tender offer statement (amended)
12:00am
CORRESP
5vw7apmd
14 May 09
Correspondence with SEC
12:00am
DEFA14A
iuqg6y 2tr
23 Mar 09
Additional proxy soliciting materials
12:00am
8-K
schaeaqtutd3kt3k
6 Mar 09
Bristol-Myers Squibb Names Andreotti President and Chief Operating Officer
12:00am
DEFA14A
bjvva9kj
24 Mar 08
Additional proxy soliciting materials
12:00am
CORRESP
woj4 fmhs
10 Oct 07
Correspondence with SEC
12:00am